Cell therapy for type-1 diabetes
-
Published:2009-12
Issue:6
Volume:3
Page:511-518
-
ISSN:1990-519X
-
Container-title:Cell and Tissue Biology
-
language:en
-
Short-container-title:Cell Tiss. Biol.
Publisher
Pleiades Publishing Ltd
Reference80 articles.
1. Abdel Aziz, M., El-Asmar, M., Haidara, M., Atta, H., Roshdy, N., Eashed, L., Sabry, D., Youssef, M., Abder Aziz, A., and Moustafa, M., Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Cardiovascular Complications in Diabetic Rats, Med. Sci. Monit., 2008, vol. 14, pp. BR249–BR255. 2. Abdi, R., Fiorina, P., Adra, C., Atkinson, M., and Sayegh, M., Immunomodulation by Mesenchymal Stem Cells. A Potential Therapeutic Strategy for Type 1 Diabetes, Diabetes, 2008, vol. 57, pp. 1759–1767. 3. Aggarwal, S. and Pittenger, M., Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses, Blood, 2005, vol. 105, pp. 1815–1822. 4. Akashi, T., Shigematsu, H., Hamamoto, Y., Iwasaki, H., Yatoh, S., Bonner-Weir, S., Akashi, K., and Weir, G., Bone Marrow or Foetal Liver Cells Fail to Induce Islet Regeneration in Diabetic Akita Mice, Diabetes Metab. Res. Rev., 2008, vol. 24, pp. 585–590. 5. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., Mclntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R., Mesenchymal Stem Cells Suppress Lymphocyte Proliferation in Vitro and Prolong Skin Graft Survival in Vivo, Exp. Hematol., 2002, vol. 30, pp. 42–48.
|
|